December 2021

Delhi Pharmaceutical Sciences and Research University (DPSRU), is the first Pharmacy University of India established by an Act7 of 2008 of State Legislature of Delhi as a State University vide Notification No.F. 2(412)/2008/SB/Vol. II/71 dated 21.01.2010 and is empowered to award degrees as specified by the UGC under section 22 of the UGC Act 1956 through its own departments and constituent colleges in regular mode vide notification No. F.9-19/2015/(CPP-I/PU) dated 22nd September 2015.

Online applications are being invited only through Google Form from eligible aspiring candidates for filling up of 04 posts vacant in various programs under National Health Mission on contract basis till 08/10/2022.

Post : Pharmcist

The Tata Memorial Centre is a Comprehensive Cancer Centre with a mission to achieve the highest standards in patient care, cancer prevention, cancer research and professional development for oncology and allied disciplines. TMC is an autonomous body funded, controlled by the Department of Atomic Energy, Government of India. TMC is affiliated to Homi Bhabha National Institute (HBNI).

Post : Senior Research Coordinator

Centre of Bio-Medical Research is committed to build a world class research institute dedicated to disease-oriented-research and to translate discoveries and observations of the laboratory into new diagnosis and therapies for the benefit of humanity.

Mankind Pharma, the 7th largest Pharmaceutical Company of India, was incepted in 1995 with a meagre capital of 50 lakhs and 20 employees. Today, we are amongst the top 5 fastest growing Pharmaceutical companies of India with an employee base of more than 10000 and heading towards a turnover of  INR 3000 crores.

Production - Formulation

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

U.S. Food and Drug Administration (FDA) has authorized the emergency use of PAXLOVID (nirmatrelvir tablets and ritonavir tablets) of pfizer for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death.

Strides Pharma gets No Objection Certificate (NOC) from Central Drugs Standard Control Organization (CDSCO) to export 50 million doses of Russia based, Sputnik vaccine which is developed by RDIF. The Russian COVID-19 vaccine Sputnik V (Gam-COVID-Vac) is an adenoviral-based, two-part vaccine against the SARS-CoV-2 coronavirus. Initially produced in Russia, Sputnik V uses a weakened virus to deliver small parts of a pathogen and stimulate an immune response.

HLL Lifecare Limited (HLL) is a Govt. of India Healthcare products manufacturing and services Company based in Thiruvananthapuram, Kerala, India under the Union Ministry of Health and Family Welfare, HLL is a global leader in the area of contraceptives, hospital products and healthcare services. With 7 manufacturing units, 5 subsidiary companies and having presence in more than 100 countries, HLL is positioned as a total healthcare solution provider catering to the well-being ofthe society at large.